Refractory psoriasis treatment with etanercept;Tratamiento de la psoriasis refractaria con etanercept

Medicina Clinica

Volumn 125, Issue 10, 2005, Pages 371-373

  Mahiques Santos, Laura ^a   Martínez Menchón, Teresa ^a   Sánchez Carazo, José Luis ^a   Pérez Ferriols, Amparo ^a   Soriano Navarr, Carlos Joaquín ^a   Fortea Baixauli, José Miguel ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Cytokines; Immune therapy; Psoriasis

Indexed keywords

CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; METHOTREXATE; RETINOID DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MALE; PSORIASIS; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TIME; TREATMENT OUTCOME;

EID: 27744524194     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13079169     Document Type: Article

References (10)

1. Kormeili T, Lowe NJ, Yamauchi PS. Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences. Br J Dermatol. 2004;151:3-15.
2. Mehlis SL, Gordon KB. The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol. 2003;49:S44-S50.
3. Goffe B, Cather JC. Etanercept: an overview. J Am Acad Dermatol. 2003;49:S105-S11.
4. Leonardi CL. Current concepts and review of efalizumab in the treatment of psoriasis. Dermatol Clin. 2004;22:427-35.
5. Gottlieb AB, Matheson RT, Lowe N, Krueger GG, Kang S, Goffe BS, et al. A randomized trial of etanercept as monotherapy for psoriasis. Arch Dermatol. 2003;139:1627-32.
6. Mease PJ, Goffe BS, Metz J, VanderStoep A, Fink B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. Lancet. 2000;356:385-90.
7. Yamauchi PS, Gindi V, Lowe N. The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy and safety. Dermatol Clin. 2004;22:449-59.
8. Mahiques Santos L, Martínez-Menchón T, Sánchez Carazo JL, Oliver Martínez V, Soriano Navarre CJ, Fortea Baixauli JM. Tratamiento de la psoriasis extensa y refractaria con infliximab. Med Clin (Barc). 2004;123:657-8.
9. Mahiques Santos L, Martínez-Menchón T, Sánchez Carazo JL, Fortea Baixauli JM. Tratamiento de la psoriasis extensa y refractaria con infliximab. Resultados tras un año de tratamiento. Med Clin (Barc). 2005;125:159.
10. Hanaver SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet. 2002;359:1541-9.